Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $26.8100 (-1.14%) ($26.7300 - $27.6100) on Tue. Jun. 9, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.05% (three month average) | RSI | 51 | Latest Price | $26.8100(-1.14%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1% a day on average for past five trading days. | Weekly Trend | EDIT declines -2.6% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(62%) IWO(58%) ARKG(57%) XBI(55%) IBUY(54%) | Factors Impacting EDIT price | EDIT will decline at least -3.025% in a week (0% probabilities). VIXM(-29%) UUP(-15%) VXX(-13%) TBT(-6%) UNG(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.025% (StdDev 6.05%) | Hourly BBV | 0 () | Intraday Trend | 0.3% | | | |
|
Resistance Level | $27.18 | 5 Day Moving Average | $27.02(-0.78%) | 10 Day Moving Average | $27.28(-1.72%) | 20 Day Moving Average | $27.18(-1.36%) | To recent high | -10.9% | To recent low | 80.2% | Market Cap | $1.665b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |